| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 14/01/2025 | 23:30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:MD | Pediatrix Medical Group Inc |
| 14/01/2025 | 22:30 | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:MD | Pediatrix Medical Group Inc |
| 13/01/2025 | 12:00 | Business Wire | Pediatrix Announces Strategic Initiatives For Enhanced Shareholder Value Creation | NYSE:MD | Pediatrix Medical Group Inc |
| 13/11/2024 | 22:30 | Edgar (US Regulatory) | Form SC 13G - Statement of Beneficial Ownership by Certain Investors | NYSE:MD | Pediatrix Medical Group Inc |
| 13/11/2024 | 22:00 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NYSE:MD | Pediatrix Medical Group Inc |
| 01/11/2024 | 12:00 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NYSE:MD | Pediatrix Medical Group Inc |
| 01/11/2024 | 11:00 | Business Wire | Pediatrix Medical Group Reports Third Quarter Results | NYSE:MD | Pediatrix Medical Group Inc |
| 16/10/2024 | 12:45 | Business Wire | Pediatrix Medical Group 2024 Third Quarter Conference Call/Webcast Scheduled for Friday, November 1, 2024 | NYSE:MD | Pediatrix Medical Group Inc |
| 04/10/2024 | 23:00 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NYSE:MD | Pediatrix Medical Group Inc |
| 06/08/2024 | 12:00 | Business Wire | Pediatrix Medical Group Reports Second Quarter Results | NYSE:MD | Pediatrix Medical Group Inc |
| 18/07/2024 | 13:00 | Business Wire | Pediatrix Medical Group 2024 Second Quarter Conference Call/Webcast Scheduled for Tuesday, August 6, 2024 | NYSE:MD | Pediatrix Medical Group Inc |
| 10/06/2024 | 18:43 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NYSE:MD | Pediatrix Medical Group Inc |
| 22/05/2024 | 12:45 | Business Wire | Pediatrix Medical Group To Present at Upcoming Investor Conferences | NYSE:MD | Pediatrix Medical Group Inc |
| 07/05/2024 | 12:00 | Business Wire | Pediatrix Medical Group Reports First Quarter Results | NYSE:MD | Pediatrix Medical Group Inc |
| 22/04/2024 | 12:45 | Business Wire | Pediatrix Medical Group 2024 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 7, 2024 | NYSE:MD | Pediatrix Medical Group Inc |
| 20/02/2024 | 13:00 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NYSE:MD | Pediatrix Medical Group Inc |
| 20/02/2024 | 12:00 | Business Wire | Pediatrix Medical Group Reports Fourth Quarter Results | NYSE:MD | Pediatrix Medical Group Inc |
| 13/02/2024 | 12:45 | Business Wire | Pediatrix® Medical Group to Host National Neonatology Meetings Feb. 19-24 | NYSE:MD | Pediatrix Medical Group Inc |
| 07/02/2024 | 12:45 | Business Wire | Pediatrix Medical Group 2023 Fourth Quarter Conference Call/Webcast Scheduled for Tuesday, February 20, 2024 | NYSE:MD | Pediatrix Medical Group Inc |
| 16/11/2023 | 20:20 | PR Newswire (US) | Miller Children's & Women's Announces New Miller Children's & Women's Neonatal Network in Partnership with Pediatrix Medical Group, Dr. Antoine Soliman Named Regional Medical Director | NYSE:MD | Pediatrix Medical Group Inc |
| 20/10/2023 | 12:45 | Business Wire | Pediatrix Medical Group 2023 Third Quarter Conference Call/Webcast Scheduled for Thursday, November 2, 2023 | NYSE:MD | Pediatrix Medical Group Inc |
| 18/07/2023 | 12:45 | Business Wire | Pediatrix Medical Group 2023 Second Quarter Conference Call/Webcast Scheduled for Thursday, August 3, 2023 | NYSE:MD | Pediatrix Medical Group Inc |
| 16/06/2023 | 23:01 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:MD | Pediatrix Medical Group Inc |
| 14/06/2023 | 22:02 | Edgar (US Regulatory) | Report of Proposed Sale of Securities (144) | NYSE:MD | Pediatrix Medical Group Inc |
| 15/05/2023 | 22:01 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NYSE:MD | Pediatrix Medical Group Inc |
| 11/05/2023 | 22:36 | Edgar (US Regulatory) | Current Report Filing (8-k) | NYSE:MD | Pediatrix Medical Group Inc |
| 10/05/2023 | 17:11 | Edgar (US Regulatory) | Schedule 13g
(sc 13g/a) | NYSE:MD | Pediatrix Medical Group Inc |
| 04/05/2023 | 22:05 | Business Wire | Pediatrix Board Appoints Sylvia Young as Independent Director | NYSE:MD | Pediatrix Medical Group Inc |
| 03/05/2023 | 12:45 | Business Wire | Pediatrix Medical Group to Present at 2023 Bank of America Health Care Conference | NYSE:MD | Pediatrix Medical Group Inc |
| 02/05/2023 | 13:02 | Edgar (US Regulatory) | Quarterly Report (10-q) | NYSE:MD | Pediatrix Medical Group Inc |
